Publications by authors named "Nikol Dibus"

Claim this Profile
R
Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.
Veera K Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto-Kokko, Olaya Esparta, Nikol Dibus

Mol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRL4 regulation of MCMBP ensures optimal licensing of DNA replication.
Anoop Kumar Yadav, Alikhan Abdirov, Katarina Ondruskova, Simran Negi, Kristina Jamrichova, Nikol Dibus

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FBXO38 is dispensable for PD-1 regulation.
Nikol Dibus, Eva Salyova, Karolina Kolarova, Alikhan Abdirov, Michele Pagano

EMBO Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential requirements for Smarca5 expression during hematopoietic stem cell commitment.
Tereza Turkova, Juraj Kokavec, Tomas Zikmund, Nikol Dibus, Kristyna Pimkova

Commun Biol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FBXO38 Ubiquitin Ligase Controls Sertoli Cell Maturation.
Nikol Dibus, Eliska Zobalova, Mario A M Monleon, Vladimir Korinek, Dominik Filipp

Front Cell Dev Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability.
Nikol Dibus, Vladimir Korinek, Lukas Cermak

Front Cell Dev Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis